Document Detail


Panobinostat shows efficacy in hodgkin lymphoma.
MedLine Citation:
PMID:  22684466     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Panobinostat monotherapy is active against relapsed or refractory Hodgkin lymphoma.
Authors:
-
Related Documents :
707726 - Mucoepidermoid carcinoma of salivary gland origin. a clinicopathologic study of 367 cases.
20670136 - Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic an...
7851176 - Observer variability in the assessment of type and dysplasia of colorectal adenomas, an...
18206496 - Reprint of: stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal g...
12525526 - Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized contr...
18348296 - Prognostic factors for high-risk early-stage epithelial ovarian cancer: a gynecologic o...
Publication Detail:
Type:  Journal Article     Date:  2012-05-10
Journal Detail:
Title:  Cancer discovery     Volume:  2     ISSN:  2159-8290     ISO Abbreviation:  Cancer Discov     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101561693     Medline TA:  Cancer Discov     Country:  United States    
Other Details:
Languages:  eng     Pagination:  OF8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  T Cells Targeting NY-ESO-1 and Melan-A Are Prognostic in Melanoma.
Next Document:  ?-Catenin Inhibition Synergizes with Imatinib to Delay CML Recurrence.